Live from the NIH registry
Studies recruiting near Tampa right now
Top 25 of 1,331 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
St. Joseph's Children's Hospital - Center for Bleeding and Clotting Disorders — Tampa, Florida (3.4 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Joseph's Hospital/Children's Hospital-Tampa — Tampa, Florida (3.4 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
University of Florida — Tampa, Florida (3.4 mi)
· Sponsor: Westat
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — St. Petersburg, Florida (21.1 mi)
· Sponsor: Daiichi Sankyo
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
USF Diabetes and Endocrinology Center — Tampa, Florida (3.4 mi)
· Sponsor: Medtronic MiniMed, Inc.
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
Advanced Solid Tumors
Phase 1, Phase 2
Interventional 83 participants sought
Comprehensive Hematology Oncology — St. Petersburg, Florida (21.1 mi)
· Sponsor: Jiangsu HengRui Medicine Co., Ltd.
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 24 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: M.D. Anderson Cancer Center
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Moffitt Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Erasca, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
University of South Florida (USF) - University of South Florida College of Medicine - Parkinson's Di — Tampa, Florida (3.4 mi)
· Sponsor: Annovis Bio Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Vitreous Associates of Florida — St. Petersburg, Florida (21.1 mi)
· Sponsor: Genentech, Inc.
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
Cytomegalovirus (CMV)
Phase 3
Interventional 80 participants sought
Johns Hopkins All Children's Hospital - Main - PIN — St. Petersburg, Florida (21.1 mi)
· Sponsor: Takeda
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
N/A
Observational 30 participants sought
Suncoast Neuroscience Associates, Inc. — St. Petersburg, Florida (21.1 mi)
· Sponsor: Takeda
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Santos Research Center, Corp - Tampa — Tampa, Florida (3.4 mi)
· Sponsor: AbbVie
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tampa, Florida (3.4 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Tampa General/USF — Tampa, Florida (3.4 mi)
· Sponsor: Magenta Medical Ltd.
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Florida Cancer Specialists - North — St. Petersburg, Florida (21.1 mi)
· Sponsor: Mirati Therapeutics Inc.
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
Unresectable Metastatic Colorectal Cancer
Phase 1
Interventional 49 participants sought
Moffit Cancer Center — Tampa, Florida (3.4 mi)
· Sponsor: Celyad Oncology SA
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Moffitt Cancer Center-International Plaza — Tampa, Florida (3.4 mi)
· Sponsor: SWOG Cancer Research Network
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
Epilepsy, Seizures
N/A
Interventional 65 participants sought
University of South Florida — Tampa, Florida (3.4 mi)
· Sponsor: Epitel, Inc.
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Tampa, Florida (3.4 mi)
· Sponsor: AstraZeneca
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Moffitt Cancer Center & Research Institute — Tampa, Florida (3.4 mi)
· Sponsor: Kura Oncology, Inc.
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Brandon, Florida (10.5 mi)
· Sponsor: Ambros Therapeutics, Inc.
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Southwest Florida Rheumatology — Riverview, Florida (11.4 mi)
· Sponsor: University of Alabama at Birmingham